Invest Ophthalmol Vis Sci. 2013 Jan 8. pii: iovs.12-10647v1. doi: 10.1167/iovs.12-10647. [Epub ahead of print]
Green tea is neuroprotective in diabetic retinopathy.
Source
Renal Pathophysiology Laboratory, University of Campinas (Unicamp), Investigation on Diabetes Complications, Faculty of Medical Sciences (FCM), Campinas, Sao Paulo, Brazil.
Abstract
PURPOSE:
Green tea (GT), widely studied for its beneficial properties in protecting against brain ischemia, is a rich source of polyphenols, particularly (-)-epigallocatechin gallate (EGCG). The results presented here demonstrate the beneficial effects of GT in diabetic retinas and in retinal cells under diabetic conditions.
METHODS:
Diabetes was induced in spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats. Treatment animals received GT orally for 12 weeks. A vehicle was administered orally to the control animals. The protective effects of GT were also evaluated in Muller and in ARPE-19 cells.
RESULTS:
In diabetic rats, there was an increase in the expression of glial fibrillary acidic protein (GFAP), oxidative retinal markers, and glutamine synthetase levels. In addition, there was a decrease in occludin and glutamate transporter and receptor. Diabetic SHR also demonstrated blood-retinal barrier breakdown and impaired electroretinography results. Muller cells exposed to high-glucose medium produced higher levels of reactive oxygen species (ROS) and glutamine synthetase but reduced levels of glutathione, glutamate transporter and glutamate receptor. Similarly, ARPE-19 cells exhibited increased ROS production accompanied by decreased expression of claudin-1 and glutamate transporter. Treatment with GT fully restored all the above-mentioned alterations in diabetic animals as well as in retinal cells.
CONCLUSIONS:
GT protected the retina against glutamate toxicity via an anti-oxidant mechanism. These findings reveal a novel mechanism by which GT protects the retina against neurodegeneration in disorders such as diabetic retinopathy.
Add a comment